Management of patients with idiopathic inflammatory myopathies (Ms) is challenging given the systemic nature of the disease, which is often complicated by potentially life-threatening manifestations and the lack of standardized treatment regimens. Aim of this review is to provide the currently available evidence for immunotherapy in the treatment of various manifestations of IIM in order to help clinicians in the daily management of these patients. (C) 2017 Elsevier B.V. All rights reserved.
机构:
Univ Kansas, Med Ctr, Dept Neurol, Neurophysiol Div,Neuromuscular Sect, Kansas City, KS 66160 USAUniv Kansas, Med Ctr, Dept Neurol, Neurophysiol Div,Neuromuscular Sect, Kansas City, KS 66160 USA
Dimachkie, Mazen M.
Barohn, Richard J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USAUniv Kansas, Med Ctr, Dept Neurol, Neurophysiol Div,Neuromuscular Sect, Kansas City, KS 66160 USA
Barohn, Richard J.
Amato, Anthony A.
论文数: 0引用数: 0
h-index: 0
机构:
Brigham & Womens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02115 USAUniv Kansas, Med Ctr, Dept Neurol, Neurophysiol Div,Neuromuscular Sect, Kansas City, KS 66160 USA